SEC Form 4 · accession 0001571049-17-000212
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Dagger
Officer — SVP, GC and Corp Secretary
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 3, 2017 | M | 200 | $11.83 | A | 200 | D | |
| Class A Common Stock | Jan 3, 2017 | S | 200 | $30.00 | D | 0 | D | |
| Class A Common Stock | Jan 4, 2017 | M | 7 | $11.83 | A | 7 | D | |
| Class A Common Stock | Jan 4, 2017 | S | 7 | $30.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Jan 3, 2017 | M | 200 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 200 | 4,000 | D |
| Option to purchase Class A Common Stock | $11.83 | Jan 4, 2017 | M | 7 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 7 | 3,993 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016.